UNICANCER

RUBY

NCT02505048

A Study to Assess the Efficacy of Rucaparib in Metastatic Breast Cancer Patients With a BRCAness Genomic Signature

Status:

Recruiting

26459-200.png

II

Phase

Line of Therapy.png

Line of Therapy

Disease Stage.png

Advanced / Metastatic

Disease Stage

Target.png

Biomarker(s)

BRCA1/2

Investigational

Product

Rucaparib

Treatment Arms

o Experimental: rucaparib